Cargando…

Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and collated information on measures to mitigate the impact of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Koningsbruggen-Rietschel, Silke, Dunlevy, Fiona, Bulteel, Veerle, Hayes, Kate, Verbrugge, Anne, Janssens, Hettie M., Dufeu, Nadine, Simmonds, Nicholas J., Dupont, Lieven J., Downey, Damian G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402966/ https://www.ncbi.nlm.nih.gov/pubmed/34454570 http://dx.doi.org/10.1186/s13063-021-05457-5

Ejemplares similares

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

P062 Impact of the SARS-CoV-2 pandemic on clinical trials in the ECFS-CTN during 2020
por: Van Koningsbruggen-Rietschel, S., et al.
Publicado: (2021)

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Disease-specific clinical trials networks: the example of cystic fibrosis
por: De Boeck, Kris, et al.
Publicado: (2016)

433: Rationale and design of an international multicenter prospective study to evaluate serologic immune responses to SARS-CoV-2 infection in persons living with cystic fibrosis: The CAR-CF study
por: Hernandez, R., et al.
Publicado: (2021)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β(1) are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa
por: Thomassen, Jan C., et al.
Publicado: (2021)

The effect of TGF-β(1) polymorphisms on pulmonary disease progression in patients with cystic fibrosis
por: Trojan, T., et al.
Publicado: (2022)

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

Airway disease on chest computed tomography of preschool children with cystic fibrosis is associated with school‐age bronchiectasis
por: Bouma, Nynke R., et al.
Publicado: (2019)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Controlled evaluation of a transition clinic for Dutch young people with cystic fibrosis
por: Peeters, Mariëlle A. C., et al.
Publicado: (2019)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants
por: Golec, Anita, et al.
Publicado: (2022)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Cystic fibrosis modulator therapy can reverse cystic bronchiectasis
por: Middleton, Peter G., et al.
Publicado: (2023)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging
por: Landini, Nicholas, et al.
Publicado: (2023)

Pulmonary Exacerbations in Adults With Cystic Fibrosis: A Grown-up Issue in a Changing Cystic Fibrosis Landscape
por: Stanford, Gemma E., et al.
Publicado: (2021)

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
por: Naehrlich, Lutz, et al.
Publicado: (2021)

Patient-Specific Modeling of Regional Antibiotic Concentration Levels in Airways of Patients with Cystic Fibrosis: Are We Dosing High Enough?
por: Bos, Aukje C., et al.
Publicado: (2015)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients
por: Orfanos, Sarah, et al.
Publicado: (2018)

The Effect of Synonymous Single-Nucleotide Polymorphisms on an Atypical Cystic Fibrosis Clinical Presentation
por: Bampi, Giovana B., et al.
Publicado: (2020)

Impact of traffic related air pollution indicators on non-cystic fibrosis bronchiectasis mortality: a cohort analysis
por: Goeminne, Pieter C, et al.
Publicado: (2014)

Identification of Critical Windows of Metabolic Programming of Metabolism and Lung Function in Male Offspring of Obese Dams
por: Dinger, Katharina, et al.
Publicado: (2020)

Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis
por: Kruizinga, Matthijs D., et al.
Publicado: (2020)

Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms
por: Murphy, Mark P., et al.
Publicado: (2016)

Mitigating the Impact of Socioeconomic Status on Listing for Lung Transplantation in Cystic Fibrosis
por: Hadjiliadis, Denis
Publicado: (2020)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease
por: Slimmen, Lisa J. M., et al.
Publicado: (2023)

Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
por: Shteinberg, Michal, et al.
Publicado: (2017)

Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients
por: Goeminne, Pieter Christian, et al.
Publicado: (2012)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients
por: Griese, Matthias, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_negbbmenhg2amn76tkqr8f7ptc